GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » EV-to-EBIT

Adherium (ASX:ADRDA) EV-to-EBIT : -0.50 (As of May. 29, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Adherium EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Adherium's Enterprise Value is A$5.68 Mil. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-11.30 Mil. Therefore, Adherium's EV-to-EBIT for today is -0.50.

The historical rank and industry rank for Adherium's EV-to-EBIT or its related term are showing as below:

ASX:ADRDA' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.67   Med: -0.09   Max: 0.82
Current: -0.5

During the past 8 years, the highest EV-to-EBIT of Adherium was 0.82. The lowest was -1.67. And the median was -0.09.

ASX:ADRDA's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 19.425 vs ASX:ADRDA: -0.50

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Adherium's Enterprise Value for the quarter that ended in Dec. 2024 was A$10.99 Mil. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-11.30 Mil. Adherium's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -102.82%.


Adherium EV-to-EBIT Historical Data

The historical data trend for Adherium's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium EV-to-EBIT Chart

Adherium Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBIT
Get a 7-Day Free Trial -1.12 -1.64 -0.91 -0.35 -0.69

Adherium Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.35 - -0.69 -

Competitive Comparison of Adherium's EV-to-EBIT

For the Medical Devices subindustry, Adherium's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adherium's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adherium's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adherium's EV-to-EBIT falls into.


;
;

Adherium EV-to-EBIT Calculation

Adherium's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5.676/-11.296
=-0.50

Adherium's current Enterprise Value is A$5.68 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-11.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adherium  (ASX:ADRDA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Adherium's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=-11.296/10.98612
=-102.82 %

Adherium's Enterprise Value for the quarter that ended in Dec. 2024 was A$10.99 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-11.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adherium EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Adherium's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Adherium Business Description

Traded in Other Exchanges
N/A
Address
447 Collins Street, Level 5, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, and North America. Maximum of it revenue is gained from Europe.

Adherium Headlines

No Headlines